Correlation Between Genscript Biotech and Nautilus Biotechnology
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Nautilus Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Nautilus Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Nautilus Biotechnology, you can compare the effects of market volatilities on Genscript Biotech and Nautilus Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Nautilus Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Nautilus Biotechnology.
Diversification Opportunities for Genscript Biotech and Nautilus Biotechnology
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Genscript and Nautilus is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Nautilus Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nautilus Biotechnology and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Nautilus Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nautilus Biotechnology has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Nautilus Biotechnology go up and down completely randomly.
Pair Corralation between Genscript Biotech and Nautilus Biotechnology
Assuming the 90 days horizon Genscript Biotech is expected to generate 0.74 times more return on investment than Nautilus Biotechnology. However, Genscript Biotech is 1.35 times less risky than Nautilus Biotechnology. It trades about -0.02 of its potential returns per unit of risk. Nautilus Biotechnology is currently generating about -0.22 per unit of risk. If you would invest 140.00 in Genscript Biotech on August 29, 2024 and sell it today you would lose (3.00) from holding Genscript Biotech or give up 2.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genscript Biotech vs. Nautilus Biotechnology
Performance |
| Timeline |
| Genscript Biotech |
| Nautilus Biotechnology |
Genscript Biotech and Nautilus Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genscript Biotech and Nautilus Biotechnology
The main advantage of trading using opposite Genscript Biotech and Nautilus Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Nautilus Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nautilus Biotechnology will offset losses from the drop in Nautilus Biotechnology's long position.| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
| Nautilus Biotechnology vs. C4 Therapeutics | Nautilus Biotechnology vs. Kymera Therapeutics | Nautilus Biotechnology vs. Foghorn Therapeutics | Nautilus Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |